Literature DB >> 17328863

Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.

Wu-Guo Deng1, Masahiko Nishizaki, Bingliang Fang, Jack A Roth, Lin Ji.   

Abstract

FHIT is a novel tumor suppressor gene located at human chromosome 3p14.2. Restoration of wild-type FHIT in 3p14.2-deficient human lung cancer cells inhibits cell growth and induces apoptosis. In this study, we analyzed potential upstream/downstream molecular targets of the FHIT protein and found that FHIT specifically targeted and regulated death receptor (DR) genes in human non-small-cell lung cancer (NSCLC) cells. Exogenous expression of FHIT by a recombinant adenoviral vector (Ad)-mediated gene transfer upregulated expression of DR genes. Treatment with a recombinant TRAIL protein, a DR-specific ligand, in Ad-FHIT-transduced NSCLC cells considerably enhanced FHIT-induced apoptosis, further demonstrating the involvement of DRs in FHIT-induced apoptosis. Moreover, we also found that FHIT targeted downstream of the DR-mediated signaling pathway. FHIT overexpression disrupted mitochondrial membrane integrity and activated multiple pro-apoptotic proteins in NSCLC cell. These results suggest that FHIT induces apoptosis through a sequential activation of DR-mediated pro-apoptotic signaling pathways in human NSCLC cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328863      PMCID: PMC1934611          DOI: 10.1016/j.bbrc.2007.02.067

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.

Authors:  H Ishii; K R Dumon; A Vecchione; L Y Fong; R Baffa; K Huebner; C M Croce
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

2.  FHIT gene therapy prevents tumor development in Fhit-deficient mice.

Authors:  K R Dumon; H Ishii; L Y Fong; N Zanesi; V Fidanza; R Mancini; A Vecchione; R Baffa; F Trapasso; M J During; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Authors:  H Ishii; K R Dumon; A Vecchione; F Trapasso; K Mimori; H Alder; M Mori; G Sozzi; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

4.  Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).

Authors:  G A Garinis; V G Gorgoulis; G Mariatos; P Zacharatos; A Kotsinas; T Liloglou; P Foukas; P Kanavaros; N G Kastrinakis; T Vassilakopoulos; T Vogiatzi; J K Field; C Kittas
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

5.  Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.

Authors:  W H Hu; H Johnson; H B Shu
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

6.  Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

Authors:  L Ji; B Fang; N Yen; K Fong; J D Minna; J A Roth
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  Muir-Torre-like syndrome in Fhit-deficient mice.

Authors:  L Y Fong; V Fidanza; N Zanesi; L F Lock; L D Siracusa; R Mancini; Z Siprashvili; M Ottey; S E Martin; T Druck; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

8.  Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Authors:  Luca Roz; Marcella Gramegna; Hideshi Ishii; Carlo M Croce; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.

Authors:  Luca Roz; Francesca Andriani; Carlos G Ferreira; Giuseppe Giaccone; Gabriella Sozzi
Journal:  Oncogene       Date:  2004-12-02       Impact factor: 9.867

Review 10.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers.

Authors:  Eugene R Zabarovsky; Michael I Lerman; John D Minna
Journal:  Oncogene       Date:  2002-10-07       Impact factor: 9.867

View more
  9 in total

1.  The effect of adenovirus-mediated gene expression of FHIT in small cell lung cancer cells.

Authors:  Roza Zandi; Kai Xu; Hans S Poulsen; Jack A Roth; Lin Ji
Journal:  Cancer Invest       Date:  2011-12       Impact factor: 2.176

2.  The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.

Authors:  David G Watson; Francesca Tonelli; Manal Alossaimi; Leon Williamson; Edmond Chan; Irina Gorshkova; Evgeny Berdyshev; Robert Bittman; Nigel J Pyne; Susan Pyne
Journal:  Cell Signal       Date:  2013-01-11       Impact factor: 4.315

3.  Adenoviral vector-based strategies for cancer therapy.

Authors:  Anurag Sharma; Manish Tandon; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Drug ther       Date:  2009-05-01

Review 4.  Mitochondrial Ca(2+) and apoptosis.

Authors:  Carlotta Giorgi; Federica Baldassari; Angela Bononi; Massimo Bonora; Elena De Marchi; Saverio Marchi; Sonia Missiroli; Simone Patergnani; Alessandro Rimessi; Jan M Suski; Mariusz R Wieckowski; Paolo Pinton
Journal:  Cell Calcium       Date:  2012-04-03       Impact factor: 6.817

5.  Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis.

Authors:  Yaping Zhang; Xiao Xu; Zhiliang Chen; Zhenhua Zhao
Journal:  Onco Targets Ther       Date:  2017-06-20       Impact factor: 4.147

6.  N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity.

Authors:  Ameneh Eslamparast; Reza Abbasgholizadeh; Seyed Nasser Ostad; Mehdi Gharghabi; Mohammad Hossein Ghahremani
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 7.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

8.  The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.

Authors:  Francesca Tonelli; Manal Alossaimi; Viswanathan Natarajan; Irina Gorshkova; Evgeny Berdyshev; Robert Bittman; David G Watson; Susan Pyne; Nigel J Pyne
Journal:  Biomolecules       Date:  2013-06-10

9.  Computational Survey of FHIT, A Putative Human Tumor Suppressor, Truncates Structure.

Authors:  Ameneh Eslamparast; Mohammad Hossein Ghahremani; Soroush Sardari
Journal:  Avicenna J Med Biotechnol       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.